Bio-Connect markets and sells a wide-ranging portfolio of leading brands from mainly research-oriented suppliers in Life Science, Diagnostics, Food, Pharma and Veterinary. In addition, the company is a full-service provider to key customers for niche Life Science research and diagnostic reagents and customized products. Its customers are mainly university and hospital laboratories as well as privately and publicly funded research organizations.
The acquisition strengthens our presence in the Benelux countries and opens up opportunities for cooperation with our other companies in
Bio-Connect has a turnover of approximately
"The acquisition of Bio-Connect means that we are strengthening our presence in an attractive segment where we already have major expertise and market presence in several European markets," says Kristina Willgård, CEO of
Closing of the acquisition takes place as of today and is expected to have only a marginal positive effect on
For further information, please contact
Kristina Willgård, CEO,
Peter Simonsbacka, Labtech Business Area Manager,
This information was issued for publication on
https://news.cision.com/addlife/r/addlife-acquires-bio-connect-group,c3406970
https://mb.cision.com/Main/13919/3406970/1462960.pdf
(c) 2021 Cision. All rights reserved., source